CompletedPhase 4NCT00746551

Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment

Studying Autosomal recessive sideroblastic anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mahidol University
Principal Investigator
Pornpimol Ruangvutilert, MD, PhD.
Obstetrics and Gynecology Department, Faculty of Medicine Siriraj Hosptial, Mahidol University
Intervention
Ferli-6® (Continental Pharm co., ltd.)(drug)
Enrollment
80 enrolled
Eligibility
18-45 years · FEMALE
Timeline
20082010

Study locations (1)

Collaborators

Vifor Pharma

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00746551 on ClinicalTrials.gov

Other trials for Autosomal recessive sideroblastic anemia

Additional recruiting or active studies for the same condition.

See all trials for Autosomal recessive sideroblastic anemia

← Back to all trials